Diagnosis and management of iron deficiency in chronic dialysis patients

Current Opinion in Nephrology and Hypertension

Volumn 9, Issue 6, 2000, Pages 669-674

  Van Zyl Smit, Roal ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; FERRIC GLUCONATE; HEMOGLOBIN; IRON; IRON DEXTRAN; IRON HYDROXYSACCHARATE; IRON POLYMALTOSE; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

ALGORITHM; CLINICAL PROTOCOL; DIAGNOSTIC PROCEDURE; DIALYSIS; DRUG INDICATION; HEMOGLOBIN DETERMINATION; HUMAN; IRON DEFICIENCY ANEMIA; IRON STORAGE; IRON THERAPY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT;

HUMANS; IRON; IRON METABOLISM DISORDERS; RENAL DIALYSIS; TIME FACTORS;

EID: 0033677710     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200011000-00013     Document Type: Review

References (39)

1. The measurement of dialyser blood loss
2. An indistinct balance: The safety and efficacy of parenteral iron therapy
3. How to diagnose and correct iron deficiency during ruEPO: A consensus report
4. Anemia management of adult hemodialysis patients in the US: Results from the 1997 ESRD Core Indicators Project
5. Percentage of hypochromic red blood cells as predictor of erythropoietic and iron response after i.v. iron supplementation in maintenance haemodialysis patients
6. Merits of percentage hypochromic red blood cells as a marker of functional iron deficiency
7. Factors determining the percentage of hypochromic red blood cells in hemodialysis patients
8. Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients
9. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients
10. Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients
11. Hypochromic red cells and reticulocyte haemoglobin content as markers of iron-deficient erythropoiesis in patients undergoing chronic hemodiaiysis
12. Intact transferrin receptors in human plasma and their relation to erythropoiesis
13. Is serum transferrin receptor a sensitive marker of iron repletion in patients with iron-deficiency anemia and hemodialysis patients?
14. Soluble transferrin receptor is correlated with erythropoietin sensitivity in dialysis patients
15. Diagnosis of iron deficiency in chronic renal failure
16. Clinical practice guidelines anemia of chronic renal failure
17. Iron management in end stage renal disease
18. Erythropoietin hyporesponsiveness: From iron deficiency to iron overload
19. Beneficial effects of adopting an aggressive intravenous iron policy in a hemodialysis unit
20. Total iron-binding capacityestimated transferrin correlates with the nutritional subjective global assessment in haemodialysis patients
21. Limited value of zinc protoporphyrin as a marker of iron status in chronic hemodialysis patients
22. Acute-phase response predicts resistance in hemodialysis and peritoneal dialysis patients
23. Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis
24. The evaluation of iron status in hemodialysis patients
25. Parenteral iron use in the management of anemia in end-stage renal disease patients
26. An evaluation of the effectiveness of oral iron therapy in haemodialysis patients receiving recombinant human erythropoietin
27. Sodium ferric gluconate complex in sucrose is safe and effective in haemodialysis patients: North American Clinical Trial
28. A randomized trial of three iron dextran infusion methods for anemia in EPO-treated dialysis patients
29. Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia
30. Toxicity of parenteral iron dextran therapy
31. A multicenter study of the safety of intravenous iron dextran in hemodialysis patients
32. Iron and cardiac disease in the end-stage renal disease setting
33. Review of issues relating to iron and infection
34. Strategies for iron supplementation: Oral versus intravenous
35. Serum amino-transferase levels as an indicator of the effectiveness of venesection for chronic hepatitis C
36. A study of parenteral iron regimens in hemodialysis patients
37. Iron metabolism and iron substitution during erythropoietin therapy
38. The therapeutic equivalence of oral and intravenous iron in renal dialysis patients
39. Intravenous iron supplementation for the treatment of the anaemia of moderate to severe chronic renal failure patients not receiving dialysis